Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis

Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis

Background. The aim of this observational study is to investigate the efficacy and safety of two approved oral disease-modifying therapies (DMTs) in patients with remitting-relapsing multiple sclerosis (RRMS): dimethyl fumarate (DMF) vs. teriflunomide (TRF). Methods. A total of 159 RRMS patients (82...

Full description

Saved in:
Bibliographic Details
Main Authors: Nasim Nehzat, Omid Mirmosayyeb, Mahdi Barzegar, Reza Vosoughi, Erfane Fazeli, Vahid Shaygannejad
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Neurology Research International
Online Access:http://dx.doi.org/10.1155/2021/6679197
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items